country

Change Language

EN - English
FR - Français
DE - Deutsch
ES - Español
JA - 日本語
KO - 한국어

Country or Region:

United States

Product Name	Size / Unit Price	Qty

Total: USD 0.00 Checkout

Art. -Nr.: HY-172018

Copy Link Print Information

CP-LC-0729

Name: CP-LC-0729
Brand: MedChemExpress
SKU: HY-172018
Price: 150.00 USD
Availability: InStock
Rating: 5 (1 reviews)

Kundenbewertung

Based on 1 Customer Validation

CP-LC-0729 is an ionizable lipid containing a thioester bond, used for mRNA/circRNA lipid nanoparticle (LNP) delivery. CP-LC-0729 possesses excellent endosomal escape capability and high biodegradability. mRNA lipid nanoparticles prepared with CP-LC-0729 exhibit lung-targeting properties. CP-LC-0729 has low cytotoxicity. CP-LC-0729 can be used for COVID-19 research.

Nur für Forschungszwecke. Wir verkaufen nicht an Patienten.

Reinheit : 99.92%
CAS. Nr.: 3040858-60-1
Formel: C₄₃H₈₅N₃O₄S
Molecular Weight:740.22

Speicherung:

Pure form -20°C, 3 years ; In solvent -80°C, 6 months , -20°C, 1 month

CP-LC-0729 Chemical Structure

CAS. Nr.: 3040858-60-1

Größe

Preis

Verfügbarkeit

Menge

Amount: USD 0.00

* Bitte wählen Sie Menge, bevor Sie Artikel hinzufügen.

Top Publications Citing

Use of MCE Products

Fluorescent Dye

Strong Fluorescence Signal / Multi-Disciplinary Applications / High Fluorescence Specificity

Biologische Aktivität
- Beschreibung
- In Vitro
- In Vivo
Chemical Information
Lösungsmittel & Löslichkeit
- In Vitro
Reinheit & Dokumentation
Verweise
Help & FAQs
Classifications
Bioz

Biologische Aktivität

Beschreibung

In Vitro

CP-LC-0729-based LNPs mainly enter HepG2 cells through lipid raft-mediated endocytosis^[2].
CP-LC-0729 (10:1 ionizable lipid/RNA weight ratio) encapsulates circRNA-Oligo (dT), with a diameter of 89.93 nm, a PDI of 0.2912, a zeta potential of −11.03 mV, and an encapsulation efficiency of 90.47%^[5].
CP-LC-0729 (0.15 mmol; 2 h) is synthesized and characterized by HPLC-CAD, mass spectrometry, and ¹H NMR, with a theoretical [M+H]⁺ of 740.63 and an observed [M+H]⁺ of 740.85^[1].

MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.

In Vivo

Viral InfectionCytokines & Chemokines

Viral Infection

Cytokines & Chemokines

CP-LC-0729-derived CPVax-CoV (i.m.) confers complete survival and protection against MA20 SARS-CoV-2 challenge in BALB/c mice^[3].

MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.

Related Protocols :

Chemical Information

CAS. Nr. 3040858-60-1
Appearance Liquid
Molecular Weight 740.22
Formel C₄₃H₈₅N₃O₄S
Color Colorless to light yellow
SMILES

O=C(CCSCCC(C(NCCN(C)C)=O)NC(C(CCCCCCCC)CCCCCC)=O)OCC(CCCCCCCC)CCCCCC
Versand

Room temperature in continental US; may vary elsewhere.

Speicherung

Pure form	-20°C	3 years
In solvent	-80°C	6 months
	-20°C	1 month

Lösungsmittel & Löslichkeit

In Vitro:

Ethanol : 25 mg/mL (33.77 mM; Need ultrasonic)

View the Complete Stock Solution Preparation Table

Preparing Stock Solutions

View the Complete Stock Solution Preparation Table

Concentration Solvent Mass

1 mg

5 mg

10 mg

Concentration

Solvent

Mass

1 mM

1.3509 mL

6.7547 mL

13.5095 mL

5 mM

0.2702 mL

1.3509 mL

2.7019 mL

10 mM

0.1351 mL

0.6755 mL

1.3509 mL

Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.

Storage method and period of stock solution: -80°C, 6 months; -20°C, 1 month. When stored at -80°C, please use it within 6 months. When stored at -20°C, please use it within 1 month.

Molaritätsrechner

Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)

Mass Mass

Konzentration Konzentration

Volumen Volumen

Molecular Weight Molecular Weight

Verdünnungsrechner

Konzentration _{(Stammlösung)} × Volumen _{(Stammlösung)} = Konzentration _{(Ziellösung)} × Volumen _{(Ziellösung)}

Konzentration _{(Stammlösung)} Konzentration _{(Stammlösung)}

Volumen _{(Stammlösung)} Volumen _{(Stammlösung)}

Konzentration _{(Ziellösung)} Konzentration _{(Ziellösung)}

Volumen _{(Ziellösung)} Volumen _{(Ziellösung)}

Reinheit & Dokumentation

Select Batch:

Reinheit: 99.98%

Assay: 99.98%

ee.: 99.98%

Data Sheet (274 KB)
SDS (252 KB)
- English - EN (252 KB)
- Français - FR (252 KB)
- Deutsch - DE (252 KB)
- Norwegian - NO (252 KB)
- Español - ES (252 KB)
- Swedish - SV (252 KB)
- Italian - IT (252 KB)
- Korean - KR (252 KB)
- Portuguese - PT (252 KB)
COA (2659 KB)
Elemental Analysis Report (2659 KB)
HNMR (2659 KB)
CNMR (2659 KB)
RP-HPLC (2659 KB)
NP-HPLC (2659 KB)
MS (2659 KB)
LCMS (2659 KB)
IR (2659 KB)
GC (2659 KB)
OR (2659 KB)
SDS-PAGE (2659 KB)
SEC-HPLC (2659 KB)
Other Report (2659 KB)
Handling Instructions (2659 KB)

Verweise

[1]. Mata E, et al. Preserved efficacy of lyophilized SARS-CoV-2 mRNA vaccine incorporating novel ionizable lipids after one year at 25 °C. NPJ vaccines. 2025 Jul 01;10(1):135.

[2]. Giménez-Warren J, et al. STAAR Lipids: A Novel Ionizable Lipid Synthetic Platform for Efficient mRNA Delivery In Vivo with Tunable Lung Targeting.

[3]. Mata E, et al. Enhanced stability and efficacy of a lyophilized mRNA SARS-CoV-2 vaccine incorporating novel Ionizable lipids after one year storage at 25ºC.

[4]. Peña Á, et al. Thioester-Containing Ionizable Lipids with Enhanced Endosomal Escape and Biodegradability for mRNA and tRNA Delivery. Pharmaceutics. 2026 Apr 13;18(4):472.

[5]. Broset E, et al. A Complete Approach for circRNA Therapeutics from Purification to Lyophilized Delivery Using Novel Ionizable Lipids. International journal of molecular sciences. 2025 May 27;26(11):5138.

[6]. El-Sehrawy AAMA, et al. Circular Logic: Engineering Next-Generation Circular RNA Therapeutics for Precision Oncology. Biotechnology and bioengineering. 2026 Aug 12.

[7]. Li X. Special Issue “Properties and Applications of Nanoparticles and Nanomaterials: ”. International journal of molecular sciences. 2025 Jul 15;26(14):6763.

Help & FAQs

How should lyophilized recombinant proteins be reconstituted and stored?

1. Before opening the cap, centrifuge the vial at 13000 rpm for 20-30 seconds. This step will ensure that any lyophilized powder that may have adhered to the cap or walls is collected at the bottom of the vial, minimizing the risk of product loss.

Complete Stock Solution Preparation Table

Storage method and period of stock solution: -80°C, 6 months; -20°C, 1 month. When stored at -80°C, please use it within 6 months. When stored at -20°C, please use it within 1 month.

Optional Solvent	Concentration Solvent Mass	1 mg	5 mg	10 mg	25 mg
Ethanol	1 mM	1.3509 mL	6.7547 mL	13.5095 mL	33.7737 mL
	5 mM	0.2702 mL	1.3509 mL	2.7019 mL	6.7547 mL
	10 mM	0.1351 mL	0.6755 mL	1.3509 mL	3.3774 mL
	15 mM	0.0901 mL	0.4503 mL	0.9006 mL	2.2516 mL
	20 mM	0.0675 mL	0.3377 mL	0.6755 mL	1.6887 mL
	25 mM	0.0540 mL	0.2702 mL	0.5404 mL	1.3509 mL
	30 mM	0.0450 mL	0.2252 mL	0.4503 mL	1.1258 mL

Bioz

Keywords

MOQ

Minimum order quantity

100 mg

Angebot einholen Auf Lager

Other size

Angebot einholen

Amount: USD 0.00

Biologische Aktivität
- Beschreibung
- In Vitro
- In Vivo
Chemical Information
Lösungsmittel & Löslichkeit
- In Vitro
Reinheit & Dokumentation
Verweise

Produktname:
Art. -Nr.:
Menge:
MCE Japan Authorized Agent:

Produktname:
CAS. Nr.:
Species:
Reinheit:
Menge:

CP-LC-0729

Biologische Aktivität

Beschreibung

In Vitro

In Vivo

Chemical Information

Lösungsmittel & Löslichkeit

In Vitro:

Reinheit & Dokumentation

Verweise

Help & FAQs

Complete Stock Solution Preparation Table

CP-LC-0729 Related Classifications

HY-172018 Related Classifications

Bioz

Keywords

Your Recently Viewed Products